S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
TSE:CRON

Cronos Group - CRON Stock Forecast, Price & News

C$3.33
-0.03 (-0.89%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
C$3.28
C$3.37
50-Day Range
C$3.24
C$4.74
52-Week Range
C$3.21
C$5.36
Volume
306,056 shs
Average Volume
218,909 shs
Market Capitalization
C$1.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$4.75

CRON stock logo

About Cronos Group (TSE:CRON) Stock

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Cannabis Stock Movers For November 16, 2022
Top Cannabis Stocks
Can Cronos Group Q3 results bring positive surprise?
Cronos Group Inc. Announces Final Settlement Agreements
See More Headlines
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Company Calendar

Today
2/02/2023
Next Earnings (Estimated)
2/27/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
626
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$4.75
High Stock Price Forecast
C$7.00
Low Stock Price Forecast
C$3.00
Forecasted Upside/Downside
+42.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$94.81 million
Cash Flow
C$1.99 per share
Book Value
C$3.16 per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.26 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Michael Ryan Gorenstein J.D. (Age 36)
    Pres, CEO & Chairman
    Comp: $389.15k
  • Ms. Shannon Buggy (Age 53)
    Sr. VP & Global Head of People
    Comp: $438.81k
  • Ms. Anna Shlimak (Age 37)
    Sr. VP of Corp. Affairs & Strategy
    Comp: $422.03k
  • Mr. James Holm
    Chief Financial Officer
  • Mr. Carlos Cortez (Age 50)
    VP, Controller & Principal Accounting Officer
  • Mr. Shayne J. Laidlaw
    Director of Investor Relations & Strategy
  • Mr. Terry Gregory-Joseph Doucet (Age 33)
    Sr. VP of Legal & Regulatory Affairs and Corp. Sec.
  • Mr. Jeffrey David Jacobson (Age 37)
    Chief Growth Officer
  • Mr. Arye Weigensberg
    Head of R&D
  • Mr. Kevin B Gifford
    VP of Fin.













CRON Stock - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CRON shares.
View CRON analyst ratings
or view top-rated stocks.

What is Cronos Group's stock price forecast for 2023?

5 analysts have issued twelve-month price targets for Cronos Group's stock. Their CRON share price forecasts range from C$3.00 to C$7.00. On average, they expect the company's share price to reach C$4.75 in the next twelve months. This suggests a possible upside of 42.6% from the stock's current price.
View analysts price targets for CRON
or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2023?

Cronos Group's stock was trading at C$3.44 at the start of the year. Since then, CRON shares have decreased by 3.2% and is now trading at C$3.33.
View the best growth stocks for 2023 here
.

When is Cronos Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our CRON earnings forecast
.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC).

What is Cronos Group's stock symbol?

Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately C$3.33.

How much money does Cronos Group make?

Cronos Group (TSE:CRON) has a market capitalization of C$1.26 billion and generates C$94.81 million in revenue each year.

How many employees does Cronos Group have?

The company employs 626 workers across the globe.

How can I contact Cronos Group?

Cronos Group's mailing address is Suite 300, Toronto, Ontario M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at 416-504-0004.

This page (TSE:CRON) was last updated on 2/2/2023 by MarketBeat.com Staff